Correlation Between Heron Therapeuti and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Heron Therapeuti and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heron Therapeuti and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Heron Therapeuti and Sangamo Therapeutics, you can compare the effects of market volatilities on Heron Therapeuti and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heron Therapeuti with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heron Therapeuti and Sangamo Therapeutics.
Diversification Opportunities for Heron Therapeuti and Sangamo Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Heron and Sangamo is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Heron Therapeuti and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Heron Therapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heron Therapeuti are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Heron Therapeuti i.e., Heron Therapeuti and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Heron Therapeuti and Sangamo Therapeutics
Given the investment horizon of 90 days Heron Therapeuti is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Heron Therapeuti is 1.39 times less risky than Sangamo Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Sangamo Therapeutics on September 19, 2024 and sell it today you would earn a total of 192.00 from holding Sangamo Therapeutics or generate 213.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Heron Therapeuti vs. Sangamo Therapeutics
Performance |
Timeline |
Heron Therapeuti |
Sangamo Therapeutics |
Heron Therapeuti and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Heron Therapeuti and Sangamo Therapeutics
The main advantage of trading using opposite Heron Therapeuti and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heron Therapeuti position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |